Results 191 to 200 of about 8,198,133 (306)
CAR-T cell therapy in china: innovations, challenges, and strategic pathways. [PDF]
Discov OncolYan L +6 more
europepmc +1 more source
B Lymphocyte: Activation by Insoluble Anti-Immunoglobulin: Induction of Immunoglobulin Secretion by a T Cell-Dependent Soluble Factor [PDF]
, 1979 David C. Parker +2 more
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Cell-cell adhesion, cell shape and cell polarity
Mechanisms of Development, 2017 openaire +2 more sources
T cell redirecting therapy for relapsed multiple myeloma. [PDF]
Discov OncolTan MSY, Hellou T, Dingli D.
europepmc +1 more source
Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. [PDF]
, 1978 T J Braciale, K. L. Yap
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation. [PDF]
Cell Mol ImmunolZhu Q +8 more
europepmc +1 more source
The Effect of T Cell Growth Factor on the Generation of Cytolytic T Cells [PDF]
, 1978 Paul E. Baker +3 more
openalex +1 more source